TECX

Conviction 84HealthcareScan · Mon, Aug 10, 2026

TECX$32.77+5.76%

ResistanceSupportVol 14Insider sell

Vol MA14 156.83K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Tectonic Therapeutic, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.tectonictx.com ↗

Price32.77

Change+5.76%

Gap+2.00%

Rel volume1.25×

Avg volume172.34K

Avg $ vol5.34M

SMA 2030.75

SMA 5031.16

SMA 20025.81

Price vs 50+5.16%

Price vs 200+26.96%

MA stackbullish

50/200 cross—

Supertrenddown · 33.04

RSI (14)58

MACD hist0.17

MACD crossbull · 0d

Stoch %K / %D97 / 69

ADX (14)21

+DI / −DI23 / 18

RSI divergence—

MACD divergence—

ATR %+5.63%

ADR %5.42%

52w high37.93

52w low14.71

From 52w high-13.62%

Above 52w low+122.74%

New 52w highNo

SqueezeOff

Bollinger width23.55%

%B0.78

Donchian pos67.05%

Donchian high35.48

Donchian low27.24

AVWAP (52w high)32.34

vs AVWAP high+1.30%

AVWAP (52w low)23.08

vs AVWAP low+41.97%

OBV trendUp

Chaikin MF (20)-0.04

Today vs 20d1.25×

Avg vol (14d)156.83K

Avg vol (20d)172.34K

Avg $ vol (20d)5.34M

Market cap640.53M

RS 3m (vs SPY)+9.60%

RS 6m (vs SPY)+21.41%

RS line new highNo

Trend template8/8

Technical rank75.1

1 week+17.35%

1 month-4.67%

3 months+12.98%

6 months+34.45%

1 year+49.48%

YTD+56.70%

P/E-8.64

P/B2.86

P/S—

P/FCF-10.62

EPS-4.05

Div yield—

ROE-33.13%

ROA-31.28%

Debt/Eq0.07

Current22.29

EV/EBITDA-5.18

Gross margin—

Net margin—

Rev growth—

EPS growth-27.89%

Price target79.75

Target upside143.40%

Analyst ratingBuy

Institutional74.42%

Ent. value428.47M

Revenue—

Net income-22.29M

Gross profit—

Free cash flow-60.29M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out18.87M

Employees60

ListedFri, Jun 21, 2024

Free float9.88M

Float %52.6%

Short interest1.94M

Days to cover7.6d

Short volume46.8%

Squeeze score73 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$1.18 vs −$1.41

Last surprise+16.3% beat

Setup gradeA

Conviction84 / 100

Pattern quality—

Tech rank75.1 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance36.46

Support27.77

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in TECX

All disclosures →

No recent disclosed trades by Congress in TECX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in TECX · 5 buys · 1 sell

Insider	Side	Shares	Value	Traded	Filed
Vitorovic Stefan Director · Stock Option (Right to Buy) · 2026-06-09	Grant	10.2K	$0	2026-06-09	2026-06-10
Donenberg Phillip B. Director · Stock Option (Right to Buy) · 2026-06-09	Grant	10.2K	$0	2026-06-09	2026-06-10
Tipirneni Praveen P. Director · Stock Option (Right to Buy) · 2026-06-09	Grant	10.2K	$0	2026-06-09	2026-06-10
SPRINGER TIMOTHY A Director · Stock Option (Right to Buy) · 2026-06-09	Grant	10.2K	$0	2026-06-09	2026-06-10
Chutter Jessica Caroline Director · Stock Option (Right to Buy) · 2026-06-08	Grant	20.4K	$0	2026-06-08	2026-06-10
Ruddy Marcella K. Chief Medical Officer · Common Stock · 2026-05-04	Sell	1.06K	$32K	2026-05-04	2026-05-06

SEC filings

EDGAR filings in TECX · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.